OPKO Health, Inc. 13D and 13G filings for GeneDx Holdings Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-20 9:36 pm Sale |
2024-11-18 | 13D | GeneDx Holdings Corp. WGS |
OPKO HEALTH INC. OPK |
1,370,841 4.990% |
-375,833 (-21.52%) |
Filing |
| 2024-11-08 5:23 pm Sale |
2024-11-06 | 13D | GeneDx Holdings Corp. WGS |
OPKO HEALTH INC. OPK |
1,746,674 6.360% |
-425,000 (-19.57%) |
Filing |
| 2024-09-18 4:13 pm Sale |
2024-09-16 | 13D | GeneDx Holdings Corp. WGS |
OPKO HEALTH INC. OPK |
2,171,674 8.060% |
-330,472 (-13.21%) |
Filing |
| 2024-08-23 5:33 pm Sale |
2024-08-22 | 13D | GeneDx Holdings Corp. WGS |
OPKO HEALTH INC. OPK |
2,502,146 9.290% |
-309,637 (-11.01%) |
Filing |
| 2024-08-12 6:27 pm Sale |
2024-08-08 | 13D | GeneDx Holdings Corp. WGS |
OPKO HEALTH INC. OPK |
2,811,783 10.440% |
-311,620 (-9.98%) |
Filing |
| 2024-07-26 7:43 pm Sale |
2024-07-24 | 13D | GeneDx Holdings Corp. WGS |
OPKO HEALTH INC. OPK |
3,123,403 11.940% |
-346,118 (-9.98%) |
Filing |
| 2024-07-05 4:14 pm Purchase |
2024-07-03 | 13D | GeneDx Holdings Corp. WGS |
OPKO HEALTH INC. OPK |
3,469,521 13.270% |
3,469,521 (New Position) |
Filing |